| # | Side effect | Count |
|---|---|---|
| 0 | DEATH | 6210 |
| 1 | FATIGUE | 2709 |
| 2 | PROSTATIC SPECIFIC ANTIGEN INCREASED | 2016 |
| 3 | DRUG INEFFECTIVE | 1989 |
| 4 | THERAPY CESSATION | 1550 |
| 5 | HOT FLUSH | 1503 |
| 6 | ASTHENIA | 1324 |
| 7 | DISEASE PROGRESSION | 1226 |
| 8 | HOSPITALISATION | 1095 |
| 9 | OFF LABEL USE | 1085 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | ACQUIRED APPARENT MINERALOCORTICOID EXCESS | 29 | 0.4677 |
| 1 | APPARENT MINERALOCORTICOID EXCESS | 23 | 0.3966 |
| 2 | HORMONE-DEPENDENT PROSTATE CANCER | 21 | 0.3000 |
| 3 | POLYNEUROPATHY IN MALIGNANT DISEASE | 17 | 0.2073 |
| 4 | PROSTATE CANCER METASTATIC | 657 | 0.1965 |
| 5 | PROSTATIC SPECIFIC ANTIGEN INCREASED | 2016 | 0.1462 |
| 6 | HORMONE-REFRACTORY PROSTATE CANCER | 152 | 0.1279 |
| 7 | PROSTATIC SPECIFIC ANTIGEN ABNORMAL | 103 | 0.0992 |
| 8 | PROSTATIC SPECIFIC ANTIGEN DECREASED | 37 | 0.0979 |
| 9 | HYPERALDOSTERONISM | 25 | 0.0725 |